Inicio › Linfoma difuso de células B grandes › Utah › Salt Lake City
Ensayos clínicos de Linfoma difuso de células B grandes en Salt Lake City, UT
12 estudios para Linfoma difuso de células B grandes buscan participantes en centros de Salt Lake City y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
ReclutandoFase 1
- Intermountain Healthcare, Salt Lake City
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
ReclutandoFase 3
- Intermountain Healthcare, Salt Lake City
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
ReclutandoFase 1/2
- Intermountain - Primary Children's Hospital ( Site 1014), Salt Lake City
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
ReclutandoFase 2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
- Intermountain Health LDS Hospital, Salt Lake City
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
ReclutandoFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
ReclutandoFase 1
- Huntsman Cancer Institute, Salt Lake City
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
ReclutandoFase 1/2
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
ReclutandoFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL
ReclutandoFase 1
- Huntsman Cancer Institute at University of Utah, Salt Lake City
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
ReclutandoFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
ReclutandoFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
ReclutandoFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Ensayos de Linfoma difuso de células B grandes en otras ciudades
- New York City, NY20 estudios
- Baldwin Park, CA19 estudios
- Los Angeles, CA18 estudios
- Houston, TX18 estudios
- Chicago, IL18 estudios
- Milwaukee, WI17 estudios
- Nashville, TN17 estudios
- Boston, MA17 estudios
- Philadelphia, PA15 estudios
- Durham, NC15 estudios
- Portland, OR15 estudios
- Cleveland, OH13 estudios
Otros estudios en Salt Lake City
- Cáncer de pulmón de células no pequeñas31 estudios
- Cáncer de seno27 estudios
- Cáncer (todos los tipos)25 estudios
- Cáncer del colon y del recto22 estudios
- Mieloma múltiple22 estudios
- Cáncer de ovario19 estudios
- Cáncer de pulmón19 estudios
- Melanoma19 estudios
- Cáncer metastásico17 estudios
- Fallo cardíaco17 estudios
- Leucemia mielógena aguda17 estudios
- Obesidad16 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.